Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Sanofi–GSK COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

    The Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. [ 3 ] [ 4 ] The Sanofi–GSK COVID‑19 vaccine was approved for medical use in the European Union in November 2022.

  3. List of COVID-19 vaccine authorizations - Wikipedia

    en.wikipedia.org/wiki/List_of_COVID-19_vaccine...

    The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...

  4. ViiV Healthcare - Wikipedia

    en.wikipedia.org/wiki/ViiV_Healthcare

    GSK plc (76.5%) Pfizer (13.5%) Shionogi (10%) Number of employees. c. 1,100 (2023) Website. viivhealthcare .com. ViiV Healthcare ( / ˈviːv / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent HIV/AIDS. Its global headquarters is located in London.

  5. GSK buys COVID, influenza vaccines from retrenching CureVac - AOL

    www.aol.com/news/gsk-buys-full-rights-covid...

    GSK, one of the world's largest vaccine manufacturers, will take control of CureVac's leading experimental vaccines to fight infections, including seasonal flu and bird flu. It will pay CureVac ...

  6. EU regulator backs use of GSK's RSV shot in adults aged ... - AOL

    www.aol.com/news/eu-regulator-backs-gsks-rsv...

    July 26, 2024 at 7:12 AM. (Reuters) -The European Union health regulator on Friday recommended expanded use of GSK's respiratory syncytial virus (RSV) vaccine in adults aged between 50 and 59. Any ...

  7. GSK Sees Strong Demand For Vaccines and Asthma Drugs ... - AOL

    www.aol.com/finance/gsk-sees-strong-demand...

    Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency ...

  8. List of GSK plc products - Wikipedia

    en.wikipedia.org/wiki/List_of_GSK_plc_products

    Fendrix (hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)) Fluarix (trivalent) & Fluarix (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) FluLaval (trivalent) & FluLaval (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) Havrix (for hepatitis A vaccine, inactivated) Hepatyrix (for hepatitis A (inactivated ...

  9. EU Digital COVID Certificate - Wikipedia

    en.wikipedia.org/wiki/EU_Digital_COVID_Certificate

    The EU Digital COVID Certificate was created to facilitate travel within the European Union. It launched in July 2021, and is available to citizens of the EU, and also to travellers from outside of the region. [2] [3] [4] By December 2022, the member states had issued more than 2 billion EU Digital COVID Certificates. [5]